Hyundai ADM Bio Inc. (187660)

Overview

ADM Korea Inc. is a dynamic contract research organization (CRO) that delivers a wide array of clinical services across Asia. Founded in 2003 and headquartered in Seoul, South Korea, the company specializes in facilitating the clinical development journey from early phase trials to late-stage studies. Its offerings encompass a comprehensive suite of services designed to support pharmaceutical, biotechnology, and medical device industries in bringing new products to market safely and efficiently. With a focus on quality, reliability, and innovation, ADM Korea Inc. positions itself as a key partner in the success of clinical trials and research projects within the region.

Products and Services

• Clinical Development Services:

  ADM Korea Inc. provides a broad range of clinical development services including medical writing, clinical operation, late phase study, data management, biostatistics, and regulatory affairs. These services are tailored to assist in the careful planning, execution, and management of clinical trials, ensuring compliance with applicable regulatory standards and achieving study objectives productively.

• Pharmacovigilance Services:

  The company offers pharmacovigilance services to ensure patient safety and compliance with global regulatory requirements. This includes case processing and safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance. ADM Korea Inc. helps in identifying, evaluating, understanding, and minimizing adverse effects or any other drug-related problems.

• Quality Assurance Services:

  Quality assurance services provided by ADM Korea Inc. ensure that all aspects of the clinical trial process are performed to the highest industry standards. These services are critical for maintaining the integrity of clinical data, ensuring regulatory compliance, and safeguarding participant welfare throughout the study lifecycle.

• Medical Microneedle Patches:

  In addition to its clinical services, ADM Korea Inc. is involved in the development, manufacturing, and sale of medical microneedle patches. These innovative products represent a significant advancement in transdermal drug delivery and cosmetic applications, offering a minimally invasive, painless, and efficient method of delivering active compounds directly into the skin.